On January 18, 2021, a mass vaccination campaign against Covid-19 was launched in Russia, and the vaccine is available now to all segments of the population. In large cities, it is possible to get vaccinated not only within the State Health System, but also in a number of private medical clinics.
COVID-19 vaccine considerations for Private: Russian Federation
- Can employers mandate the vaccine?
- Who will control delivery of the vaccine?
- Who covers the cost of the vaccine?
Public health service
- Where will people get vaccinated?
Government designated vaccination locations
- Is there cultural resistance to getting the vaccine?
Currently, two different vaccines are available for people to get vaccinated in Russia: Sputnik V and EpiVacCorona. Both vaccines are Russian-made. The third vaccine – CoviVac (developed by Vaccine Research Institute named after M.P. Chumakov) has passed all registration phases and has been launched into civil circulation at the end of March 2021 (so far in a restricted scope). As foreign-made vaccines (i.g. of Moderna, Pfizer, AstraZeneca etc) have not passed the registration procedure in Russia, they are not available locally.
According to official statistics, more than 4,7 mln of Russian citizens have already been vaccinated by both components of the vaccine (both Sputnik V and EpiVacCorona need to be injected twice) and another 3 mln of the Russians have got the first component of it (out of the two required).
The official website, which publishes all the necessary information from the very beginning of the pandemic, is the following: стопкоронавирус.рф.
For more information about vaccines have a look at : вакцина.стопкоронавирус.рф.
All information is in Russian only.
Employee Benefits in Private: Russian Federation
Get insights on mandatory and common supplementary employee benefits in Private: Russian Federation.
Top 6 Vaccine Considerations
Use our decision matrix to help support your employees.
Page last modified: April 8, 2021
The information presented on this site is current as of the date initially posted; and, because matters related to COVID-19, the vaccine, and compliance measures are changing so quickly, it may not be current as of the date you read it. While the information gathered here is from Asinta global partners who are subject matter experts in their respective fields, this information is not meant to be a substitute for individual legal or medical advice, or as a substitute for advice in your specific situation.